Fig. 6From: A paclitaxel and microRNA-124 coloaded stepped cleavable nanosystem against triple negative breast cancerThe safety of the PTX/miR124-NP treatment. a The profiles of variations in mouse body weight during treatment. b Organ indexes of the heart, liver, spleen, lung and kidney from mice following treatment with various formulations. c, d Impact on the serum AST (c) and ALT (d) levels. e Impact on the serum CREA levels. f Representative H&E staining images of the heart, liver, spleen, lung and kidney tissue sections collected from mice at the end of treatment. NS indicates no statistical significance, *P < 0.05Back to article page